PROMETHEUS BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
PROMETHEUS BIOSCIENCES, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $23.54 per share as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2023-05-09
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $23.54.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $22.40.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $15.62.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $15.47.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2023-03-31 | $23.54 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $22.40 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $15.62 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $15.47 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $12.60 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $12.18 10-K · filed 2023-02-28 | |
| 2021-09-30 | $6.17 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $5.18 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $4.59 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.90 10-K · filed 2022-03-09 | $2.10 10-Q · filed 2021-05-13 |